Agios Reports Business Highlights and Second Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% on concerns over AI buildout costs, Fed rate outlook
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil prices fall as investors focus on Hormuz flows after peace talks
- SpaceX slides, tech stocks dip — what’s moving markets
- Deutsche Bank cuts gold outlook as Fed repricing weighs on prices
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Agios Pharma (AGIO) Misses Q2 EPS by 17c
August 1, 2019 7:45 AM EDTAgios Pharma (NASDAQ: AGIO) reported Q2 EPS of ($1.87), $0.17 worse than the analyst estimate of ($1.70). Revenue for the quarter came in at $26.2 million versus the consensus estimate of $27.05 million.
For earnings history and earnings-related data on Agios Pharma (AGIO) click here.
... More